Total Funding
87
59
Total FundingSeries C raised
Growth Score 87 in past quarter
-2 pts
Heat Score 59 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39003
Carlsmed manufactures and sells digital-to-device 3-D printed implant system for lumbar spine surgery.
- Jay Li: Investor
- Sharon Schulzki: Chief Operating OfficerPast Role: NSpine, Chief Operating Officer / Executive Vice President, N-Spine
About the Company
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbar
fusion surgery.
Carlsmed was founded in 2018 and is headquartered in San Diego, California.
